NCT02746757View on ClinicalTrials.gov

Glucagon Like Peptide-1 in Remote Ischemic Conditioning

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

January 31, 2018

Conditions
Healthy Volunteers
Interventions
OTHER

Remote conditioning

DRUG

Exendin 9-39

Trial Locations (1)

17176

Karolinska Institutet, Karolinska University Hospital, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT02746757 - Glucagon Like Peptide-1 in Remote Ischemic Conditioning | Biotech Hunter | Biotech Hunter